Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenoxicam + HA vs PRP + HA for TMJ Internal Derangement
NCT06572904Phase 2Active, not recruiting
- Sponsor
- Mansoura University
- Start
- Feb 2024
- Primary completion
- Oct 2024
- Modality
- Hydrogel Systems, Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of tenoxicam, autologous platelet rich gel in temporomandibular joint internal derangement (TMJID), sponsored by Mansoura University. Started Feb 2024; status: active, not recruiting.
02
Drugs
tenoxicamautologous platelet rich gel
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT06572904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06572904.